{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:27:53Z","timestamp":1760027273467,"version":"3.40.5"},"reference-count":19,"publisher":"Instituto Nacional de Salud (Colombia)","issue":"Supl. 1","content-domain":{"domain":["revistabiomedica.org"],"crossmark-restriction":false},"short-container-title":["biomedica"],"abstract":"<jats:p>Introducci\u00f3n. Staphylococcus aureus es una de las principales causas de bacteriemia, adquirida en la comunidad o asociada con la atenci\u00f3n en salud, la cual presenta un gran porcentaje de complicaciones y elevadas tasas de morbilidad y mortalidad. Los criterios SRIS (Systemic Inflammatory Response Syndrome) se han usado tradicionalmente con el fin de establecer la presencia de sepsis; sin embargo, recientemente se ha cuestionado su valor predictivo dada su baja sensibilidad y especificidad. En el 2016, apareci\u00f3 la escala qSOFA (quick Sequential Organ Failure Assessment), como una nueva herramienta para la evaluaci\u00f3n r\u00e1pida de las infecciones en los servicios de urgencias.Objetivo. Comparar las herramientas qSOFA y SRIS para la predicci\u00f3n de la bacteriemia por S. aureus.Materiales y m\u00e9todos. Se hizo un estudio observacional sobre el comportamiento cl\u00ednico de pacientes con bacteriemia por S. aureus para evaluar el perfil de resistencia fenot\u00edpica, algunas caracter\u00edsticas sociodemogr\u00e1ficas, cl\u00ednicas y de laboratorio, las complicaciones y la mortalidad, as\u00ed como los resultados de las evaluaciones con la escala qSOFA y los criterios SRIS, para establecer cu\u00e1l podr\u00eda predecir mejor la presencia de bacteriemia por S. aureus.Resultados. Se seleccionaron 26 pacientes con bacteriemia, en cuyas muestras S. aureus hab\u00eda sido el segundo germen m\u00e1s frecuentemente aislado. Se encontr\u00f3 una mortalidad del 50 % (13 casos) y una prevalencia del 30 % de S. aureus resistente a meticilina (SARM). Seg\u00fan los puntajes cl\u00ednicos obtenidos, la escala qSOFA fue positiva en 30,8 % de los pacientes y los criterios SRIS lo fueron en el 92,3 %.Discusi\u00f3n. Se encontr\u00f3 una elevada mortalidad en la poblaci\u00f3n analizada. La escala qSOFA fue menos efectiva para el diagn\u00f3stico que los criterios cl\u00e1sicos de reacci\u00f3n inflamatoria sist\u00e9mica.<\/jats:p>","DOI":"10.7705\/biomedica.4943","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T21:32:34Z","timestamp":1590615154000},"page":"125-131","update-policy":"https:\/\/doi.org\/10.7705\/crossmark","source":"Crossref","is-referenced-by-count":1,"title":["Comparaci\u00f3n de la escala qSOFA para evaluar la falla org\u00e1nica secuencial y los criterios SIRS para sepsis a la cabecera de pacientes con bacteriemia por Staphylococcus aureus"],"prefix":"10.7705","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-4850","authenticated-orcid":false,"given":"\u00d3scar","family":"Garc\u00eda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Granados","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Garz\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4444","published-online":{"date-parts":[[2020,5,1]]},"reference":[{"key":"97836","doi-asserted-by":"crossref","unstructured":"Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM Consensus Conference Committee. American College of Chest Physicians\/Society of Critical Care Medicine. Chest. 1992;101:1644-55. https:\/\/doi.org\/10.1378\/chest.101.6.1644","DOI":"10.1378\/chest.101.6.1644"},{"key":"97837","doi-asserted-by":"crossref","unstructured":"Kaukonen K, Bailey M, Pilcher D, Cooper J, Bellomo R. Systemic inflammatory response syndrome criteria in defining severe sepsis. N Engl J Med. 2015;372:1629-38. https:\/\/doi.org\/10.1056\/NEJMoa1415236","DOI":"10.1056\/NEJMoa1415236"},{"key":"97838","doi-asserted-by":"crossref","unstructured":"\u00c1lvaro-Meca A, Jim\u00e9nez-Sousa MA, Micheloud D, S\u00e1nchez-L\u00f3pez A, Heredia-Rodr\u00edguez M, Tamayo E, et al. Epidemiological trends of sepsis in the twenty-first century (2000-2013): An analysis of incidence, mortality, and associated costs in Spain. Popul Health Metr. 2018;16:4. https:\/\/doi.org\/10.1186\/s12963-018-0160-x","DOI":"10.1186\/s12963-018-0160-x"},{"key":"97839","doi-asserted-by":"crossref","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 200634:1589-96. https:\/\/doi.org\/10.1097\/01.CCM.0000217961.75225.E9","DOI":"10.1097\/01.CCM.0000217961.75225.E9"},{"key":"97840","doi-asserted-by":"crossref","unstructured":"Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315:762-74. https:\/\/doi.org\/10.1001\/jama.2016.0288","DOI":"10.1001\/jama.2016.0288"},{"key":"97841","doi-asserted-by":"crossref","unstructured":"Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: Predictors of 30-day mortality in a large cohort. Clin Infect Dis. 2000;31:1170-4. https:\/\/doi.org\/10.1086\/317421","DOI":"10.1086\/317421"},{"key":"97842","doi-asserted-by":"crossref","unstructured":"Keynan Y, Rubinstein E. Staphylococcus aureus bacteremia, risk factors, complications, and management. Crit Care Clin. 2013;29:547-62. https:\/\/doi.org\/10.1016\/j.ccc.2013.03.008","DOI":"10.1016\/j.ccc.2013.03.008"},{"key":"97843","doi-asserted-by":"crossref","unstructured":"Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603-61. https:\/\/doi.org\/10.1128\/CMR.00134-14","DOI":"10.1128\/CMR.00134-14"},{"key":"97844","doi-asserted-by":"crossref","unstructured":"Cecconi M, Evans L, Levy M, Rhodes A. Sepsis and septic shock. Lancet. 2018;392:75-87. https:\/\/doi.org\/10.1016\/S0140-6736(18)30696-2","DOI":"10.1016\/S0140-6736(18)30696-2"},{"key":"97845","doi-asserted-by":"crossref","unstructured":"Wang J, Hsu L, Lauderdale T, Fan W, Wang F. Comparison of outcomes among adult patients with nosocomial bacteremia caused by methicillin-susceptible and methicillin-resistant Staphylococcus aureus: A retrospective cohort study. PLoS One. 2015;10:e0144710. https:\/\/doi.org\/10.1371\/journal.pone.0144710","DOI":"10.1371\/journal.pone.0144710"},{"key":"97846","doi-asserted-by":"crossref","unstructured":"Kaasch A, Barlow G, Edgeworth J, Fowler V, Hellmich M, Hopkins S, et al. Staphylococcus aureus bloodstream infection: A pooled analysis of five prospective, observational studies. J Infect. 2014;68:242-51. https:\/\/doi.org\/10.1016\/j.jinf.2013.10.015","DOI":"10.1016\/j.jinf.2013.10.015"},{"key":"97847","doi-asserted-by":"crossref","unstructured":"Yilmaz M, Elaldi N, Balkan \u0130, Arslan F, Bat\u0131rel A, Bak\u0131c\u0131 M, et al. Mortality predictors of Staphylococcus aureus bacteremia: A prospective multicenter study. Ann Clin Microbiol Antimicrob. 2016;15:7. https:\/\/doi.org\/10.1186\/s12941-016-0122-8","DOI":"10.1186\/s12941-016-0122-8"},{"key":"97848","doi-asserted-by":"crossref","unstructured":"Serafim R, Gomes J, Salluh J, P\u00f3voa P. A comparison of the quick-SOFA and systemic inflammatory response syndrome criteria for the diagnosis of sepsis and prediction of mortality: A systematic review and meta-analysis. Chest. 2018;153:646-55. https:\/\/doi.org\/10.1016\/j.chest.2017.12.015","DOI":"10.1016\/j.chest.2017.12.015"},{"key":"97849","doi-asserted-by":"crossref","unstructured":"Minejima E, Delayo V, Lou M, Pamela N, Nieberg P, Rosemary C, et al. Utility of qSOFA score in identifying patients at risk for poor outcome in Staphylococcus aureus bacteremia. BMC Infect Dis. 2019;19:149. https:\/\/doi.org\/10.1186\/s12879-019-3770-4","DOI":"10.1186\/s12879-019-3770-4"},{"key":"97850","doi-asserted-by":"crossref","unstructured":"Yu H, Nie L, Liu A, Wu K, Hsein Y, Yen D, et al. Combining procalcitonin with the qSOFA and sepsis mortality prediction. Medicine (Baltimore). 2019;98:e15981. https:\/\/doi.org\/10.1097\/MD.0000000000015981","DOI":"10.1097\/MD.0000000000015981"},{"key":"97851","doi-asserted-by":"crossref","unstructured":"Chang S, Yeh C, Chen Y, Hsu C, Chen J, Chen W, et al. Quick-SOFA score to predict mortality among geriatric patients with influenza in the emergency department. Medicine (Baltimore). 2019;98:e15966. https:\/\/doi.org\/10.1097\/MD.0000000000015966","DOI":"10.1097\/MD.0000000000015966"},{"key":"97852","doi-asserted-by":"crossref","unstructured":"Herzke CA, Chen LF, Anderson DJ, Choi Y, Sexton DJ, Kaye KS. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: No better than a coin toss. Infect Control Hosp Epidemiol. 2009;30:1057-61. https:\/\/doi.org\/10.1086\/606163","DOI":"10.1086\/606163"},{"key":"97853","doi-asserted-by":"crossref","unstructured":"Carvalho K, Mamizuka E, Gontijo F. Methicillin\/oxacillin-resistant Staphylococcus aureus as a hospital and public health threat in Brazil. Braz J Infect Dis. 2010;14:71-6. https:\/\/doi.org\/10.1016\/S1413-8670(10)70014-3","DOI":"10.1016\/S1413-8670(10)70014-3"},{"key":"97854","doi-asserted-by":"crossref","unstructured":"Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol. 2007;28:273-9. https:\/\/doi.org\/10.1086\/512627","DOI":"10.1086\/512627"}],"container-title":["Biom\u00e9dica"],"original-title":[],"link":[{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/4943\/4476","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/download\/4943\/4476","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T19:50:31Z","timestamp":1590781831000},"score":1,"resource":{"primary":{"URL":"https:\/\/revistabiomedica.org\/index.php\/biomedica\/article\/view\/4943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":19,"journal-issue":{"issue":"Supl. 1","published-online":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.7705\/biomedica.4943","relation":{},"ISSN":["2590-7379","0120-4157"],"issn-type":[{"type":"electronic","value":"2590-7379"},{"type":"print","value":"0120-4157"}],"subject":[],"published":{"date-parts":[[2020,5,1]]},"assertion":[{"value":"2020-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}},{"value":"Yes","order":0,"name":"peer_reviewed","label":"Peer Reviewed","group":{"name":"peer_review","label":"Peer Review"}},{"value":"Instituto Nacional de Salud","name":"publisher","label":"This article is maintained by"},{"value":"Biomedica","name":"journaltitle","label":"Journal Title"},{"value":"Original articles","name":"content_type","label":"Content Type"}]}}